Javascript must be enabled to continue!
Naratuximab emtansine (IMGN529; Debo 1562) Drug Description
View through CrossRef
Naratuximab emtansine, also known as IMGN529 and Debio 1562 is an antibody-drug conjugate (ADC) or immunoconjugate that consists of a humanized IgG1 antibody K7153A against the cell-surface antigen CD37, a member of the tetraspanin superfamily of cell surface antigens found on B-cell malignancies, that is covalently linked via the uncleavable, maleimide-derived thioether-based linker SMCC to the maytansinoid DM1, with potential pro-apoptotic and cytotoxic activities.
Title: Naratuximab emtansine (IMGN529; Debo 1562) Drug Description
Description:
Naratuximab emtansine, also known as IMGN529 and Debio 1562 is an antibody-drug conjugate (ADC) or immunoconjugate that consists of a humanized IgG1 antibody K7153A against the cell-surface antigen CD37, a member of the tetraspanin superfamily of cell surface antigens found on B-cell malignancies, that is covalently linked via the uncleavable, maleimide-derived thioether-based linker SMCC to the maytansinoid DM1, with potential pro-apoptotic and cytotoxic activities.
Related Results
Potential drug–drug interactions and associated factors among hospitalized cardiac patients at Jimma University Medical Center, Southwest Ethiopia
Potential drug–drug interactions and associated factors among hospitalized cardiac patients at Jimma University Medical Center, Southwest Ethiopia
Background: Concomitant use of several drugs for a patient is often imposing increased risk of drug–drug interactions. Drug–drug interactions are a major cause for concern in patie...
An Evaluation of the Chester County (PA) Drug Court Program
An Evaluation of the Chester County (PA) Drug Court Program
The Chester County (PA) Drug Court Program was implemented in October of 1997. By the end of January of 1999, 184 drug offenders had participated in the program. This evaluation of...
Diverse mutant selection windows shape spatial heterogeneity in evolving populations
Diverse mutant selection windows shape spatial heterogeneity in evolving populations
ABSTRACTMutant selection windows (MSWs), the range of drug concentrations that select for drug-resistant mutants, have long been used as a model for predicting drug resistance and ...
Study Of Drug Interaction in Diabetes Mellitus Therapy at the Inpatient Installation of Al Islam Hospital Bandung
Study Of Drug Interaction in Diabetes Mellitus Therapy at the Inpatient Installation of Al Islam Hospital Bandung
The patient's clinical outcome can be influenced by drug related problems, one of which is drug interactions, because the more complex the therapy carried out, it will be in line ...
TO ESTIMATE THE INCIDENCE OF POTENTIAL DRUG-DRUG INTERACTION IN STROKE PATIENTS ADMITTED IN A TERTIARY CARE HOSPITAL, TELANGANA
TO ESTIMATE THE INCIDENCE OF POTENTIAL DRUG-DRUG INTERACTION IN STROKE PATIENTS ADMITTED IN A TERTIARY CARE HOSPITAL, TELANGANA
Objective: To determine the frequency and pattern of potential drug-drug interactions in hospitalized stroke patients.
Methods: A retrospective study was carried out among pa...
Clinical Pharmacist Intervention on Drug‐Related Problems among Elderly Patients Admitted to Medical Wards of Northwest Ethiopia Comprehensive Specialized Hospitals: A Multicenter Prospective, Observational Study
Clinical Pharmacist Intervention on Drug‐Related Problems among Elderly Patients Admitted to Medical Wards of Northwest Ethiopia Comprehensive Specialized Hospitals: A Multicenter Prospective, Observational Study
Background: Drug therapy in the elderly needs an emphasis on age‐related changes in drug pharmacokinetics and pharmacodynamics profile. Hospitalized elderly patients are at risk of...
Advanced Strategy and Future Perspectives in Drug Delivery System
Advanced Strategy and Future Perspectives in Drug Delivery System
One of the main issues with the drug delivery system is delivering the drug to specific target site with anticipated concentration to produce a desired therapeutic potential of the...
Drug Metabolism and Interactions in Pediatric Patients
Drug Metabolism and Interactions in Pediatric Patients
AbstractInfants and children are different from adults, also in the way they handle (pharmacokinetics, PK) and subsequently respond (pharmacodynamics) to drugs. Developmental PK fo...

